The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Mutations in SRD5B1 ( AKR1D1 ), the gene encoding Δ 4 -3-oxosteroid 5β-reductase, in hepatitis and liver failure in infancy
Open accessAbstract
BACKGROUND: A substantial group of patients with cholestatic liver disease in infancy excrete, as the major urinary bile acids, the glycine and taurine conjugates of 7alpha-hydroxy-3-oxo-4-cholenoic acid and 7alpha,12alpha-dihydroxy-3-oxo-4-cholenoic acid. It has been proposed that some (but not all) of these have mutations in the gene encoding delta(4)-3-oxosteroid 5beta-reductase (SRD5B1; AKR1D1, OMIM 604741). AIMS: Our aim was to identify mutations in the SRD5B1 gene in patients in whom chenodeoxycholic acid and cholic acid were absent or present at low concentrations in plasma and urine, as these seemed strong candidates for genetic 5beta-reductase deficiency. PATIENTS AND SUBJECTS: We studied three patients with neonatal onset cholestatic liver disease and normal gamma-glutamyl transpeptidase in whom 3-oxo-delta(4) bile acids were the major bile acids in urine and plasma and saturated bile acids were at low concentration or undetectable. Any base changes detected in SRD5B1 were sought in the parents and siblings and in 50 ethnically matched control subjects. METHODS: DNA was extracted from blood and the nine exons of SRD5B1 were amplified and sequenced. Restriction enzymes were used to screen the DNA of parents, siblings, and controls. RESULTS: Mutations in the SRD5B1 gene were identified in all three children. Patient MS was homozygous for a missense mutation (662 C>T) causing a Pro198Leu amino acid substitution; patient BH was homozygous for a single base deletion (511 delT) causing a frame shift and a premature stop codon in exon 5; and patient RM was homozygous for a missense mutation (385 C>T) causing a Leu106Phe amino acid substitution. All had liver biopsies showing a giant cell hepatitis; in two, prominent extramedullary haemopoiesis was noted. MS was cured by treatment with chenodeoxycholic acid and cholic acid; BH showed initial improvement but then deteriorated and required liver transplantation; RM had advanced liver disease when treatment was started and also progressed to liver failure. CONCLUSIONS: Analysis of blood samples for SRD5B1 mutations can be used to diagnose genetic 5beta-reductase deficiency and distinguish these patients from those who have another cause of 3-oxo-delta(4) bile aciduria, for example, severe liver damage. Patients with genetic 5beta-reductase deficiency may respond well to treatment with chenodeoxycholic acid and cholic acid if liver disease is not too advanced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inherited mutations in AKR1D1 have been studied in patients with bile-acid deficiency that develops in infants and is characterized by reduced formation of bile acids and accumulation of Δ4-3-keto and 5α-reduced (allo-bile acids) which are hepatotoxic.”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [95]
In the citing paper
“seven point mutations have been identified in patients with 5β-reductase deficiency: Leu106Phe, Pro133Arg, Gly223Glu, Pro198Leu, Asp241Val, Arg261Cys and Arg266Glu [95–97, 99, 100].”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [95]
In the citing paper
“This deficiency is exacerbated by the inability to from sufficient bile acids to feed-back and inhibit the rate determining step in the pathway, 7α-hydroxylase (CYP7A1), and thus the formation of allo-bile acids will be further elevated [95–99].”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [95]
In the citing paper
“So far SNPs in AKR1C1, AKR1C2 and AKR1C4 have been studied at the protein level and Phe46Tyr has been associated with disease [95–97, 99, 103, 104].”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [95]
In the citing paper
“Mutations of AKR1D1 lead to severely reduced to completely absent urinary 5β-reduced steroid excretion and hepatic failure, as AKR1D1 is essentially involved in hepatic bile acid synthesis, but no other clinical manifestations (Gonzales et al., 2004, Lemonde et al., 2003, Palermo et al., 2008).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Lemonde et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. H. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 647
Comparative anatomy of the aldo–keto reductase superfamily
Jez, J. M., BENNETT, M. J., Schlegel, B. P., Lewis, M., & Penning, T. M. (1997) · Biochemical Journal · doi:10.1042/bj3260625 · Cited by 603
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
Edwards, P. A., Kast-Woelbern, H. R., & Anisfeld, A. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30180-2 · Cited by 387
Setchell, K. D., Schwarz, M., O'Connell, N. C., Lund, E. G., Davis, D. L., Lathe, R., Thompson, H. R., Weslie Tyson, R., Sokol, R. J., & Russell, D. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2962 · Cited by 375
Peroxisome biogenesis disorders
Gould, S. J., & Valle, D. L. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02056-4 · Cited by 354
Control of messenger RNA stability in higher eukaryotes
Ross, J. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)10016-0 · Cited by 313
Setchell, K. D. R., Suchy, F. J., Welsh, M. B., Zimmer-Nechemias, L., Heubi, J. E., & Balistreri, W. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113837 · Cited by 254
Cui, J., Huang, L., Zhao, A., Lew, J.-L., Yu, J., Sahoo, S. P., Meinke, P. T., Royo, I., Peláez, F., & Wright, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209323200 · Cited by 247
Clayton, P. T., Leonard, J. V., Lawson, A. M., Setchell, K. D. R., Andersson, S., Egestad, B., & Sjövall, J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112915 · Cited by 216
Self-citationSetchell, K. D. R., Heubi, J. E., Bove, K. E., O’Connell, N. C., Brewsaugh, T., Steinberg, S. J., Moser, A. B., & Squires, R. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50017 · Cited by 175
Research works printed but not linked: 6
- 1988, Lancet, 1, 1283
- 1997, Lancet, 349, 329
- Lemonde HA. A study using tandem mass spectrometry and molecular biological techniques to facilitate the diagnosis of inborn errors of bile acid synthesis, with particular reference to Δ 4 -3-oxosteroid 5β-reductase deficiency, PhD thesis. London: University of London, 2000.
- 10.1042/BST0290298 · DOI
- 1991, J Pediatr Gastroenterol Nutr, 12, 383
- 1996, Hepatology, 23, 115
Cited by
Sorted by citations
Bile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120023 · Cited by 1,662
The aldo-keto reductases (AKRs): Overview
Penning, T. M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.024 · Cited by 565
The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and Detoxification
Barski, O. A., Tipparaju, S. M., & Bhatnagar, A. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530802431439 · Cited by 560
Human aldo–keto reductases: Function, gene regulation, and single nucleotide polymorphisms
Penning, T. M., & Drury, J. E. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.04.024 · Cited by 270
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“Mutations of AKR1D1 lead to severely reduced to completely absent urinary 5b-reduced steroid excretion and hepatic failure, as AKR1D1 is essentially involved in hepatic bile acid synthesis, but no other clinical manifestations (Gonzales et al., 2004; Lemonde et al., 2003; Palermo et al., 2008).”
Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism
Rižner, T. L., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2013.10.012 · Cited by 217
Bile acids: analysis in biological fluids and tissues
Griffiths, W. J., & Sjövall, J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r001941-jlr200 · Cited by 220
Disorders of bile acid synthesis
Clayton, P. T. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9259-3 · Cited by 170
Self-citationStructural and functional biology of aldo-keto reductase steroid transforming enzymes
Penning, T. M., Wangtrakuldee, P., & Auchus, R. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00089 · Cited by 164
Bile acid analysis in human disorders of bile acid biosynthesis
Vaz, F. M., & Ferdinandusse, S. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.003 · Cited by 155
Bile Acid Synthetic Defects and Liver Disease: A Comprehensive Review
Bove, K. E., Heubi, J. E., Balistreri, W. F., & Setchell, K. D. R. (2002) · Pediatric and Developmental Pathology · doi:10.1007/s10024-002-1201-8 · Cited by 152
Mechanisms of disease: inborn errors of bile acid synthesis
Sundaram, S. S., Bove, K. E., Lovell, M. A., & Sokol, R. J. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1179 · Cited by 146
Qiu, Y., Gong, J., Feng, J., Wang, R., Han, J., Liu, T., Lu, Y., Li, L., Zhang, M., Sheps, J. A., et al. (2016) · Hepatology · doi:10.1002/hep.29020 · Cited by 139
Defects in Bile Acid Biosynthesis‐Diagnosis and Treatment
Setchell, K. D. R., & Heubi, J. E. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000226386.79483.7b · Cited by 137
Gonzales, E. M., Gerhardt, M. F., Fabrè, M., Setchell, K. D. R., Spraul, A., Vincent, I., Heubi, J. E., Bernard, O., & Jacquemin, E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.043 · Cited by 126
EASL Clinical Practice Guidelines on genetic cholestatic liver diseases
Verkade, H. J., Felzen, A., Keitel, V., Thompson, R. J., Gonzales, E. M., Strnad, P., Kamath, B. M., & van Mil, S. W. C. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.006 · Cited by 105
Nikolaou, N., Gathercole, L., Marchand, L., Althari, S., Dempster, N. J., Green, C., van de Bunt, M., McNeil, C. A., Arvaniti, A., Hughes, B. A., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153947 · Cited by 86
Di Costanzo, L., Drury, J. E., Penning, T. M., & Christianson, D. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801778200 · Cited by 79
Hegarty, R., Deheragoda, M. G., Fitzpatrick, E., & Dhawan, A. K. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.006 · Cited by 75
Gonzales, E. M., Matarazzo, L., Franchi‐Abella, S., Dabadie, A., Cohen, J., Habès, D., Hillaire, S., Guettier, C., Taburet, A., Myara, A., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0920-5 · Cited by 71
Gómez, C., Stücheli, S., Kratschmar, D. V., Bouitbir, J., & Odermatt, A. (2020) · Metabolites · doi:10.3390/metabo10070282 · Cited by 68
Wei, H., Suo, C., Gu, X., Shen, S., Lin, K., Zhu, C., Yan, K., Bian, Z., Chen, L., Zhang, T., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.011 · Cited by 72
Gonzales, E., Cresteil, D., Baussan, C., Dabadie, A., Gerhardt, M.-F., & Jacquemin, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.024 · Cited by 68
Review article: therapeutic bile acids and the risks for hepatotoxicity
Ashby, K., Almario, E. N., Tong, W., Borlak, J. T., Mehta, R., & Chen, M. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14678 · Cited by 66
Metabolic Liver Disease in Children
Hansen, K., & Horslen, S. P. (2008) · Liver Transplantation · doi:10.1002/lt.21470 · Cited by 61
Zhang, L., Jin, Y., Huang, M. T., & Penning, T. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00193 · Cited by 68
5β-Reduced steroids and human Δ4-3-ketosteroid 5β-reductase (AKR1D1)
Chen, M., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.01.013 · Cited by 55
Human Δ4-3-oxosteroid 5β-reductase (AKR1D1) deficiency and steroid metabolism
Palermo, M., Marazzi, M. G., Hughes, B. A., Stewart, P. M., Clayton, P. T., & Shackleton, C. H. L. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.001 · Cited by 55
Self-citationDrury, J. E., Mindnich, R., & Penning, T. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127779 · Cited by 51
Metabolic liver disease in children
Hansen, K., & Horslen, S. P. (2008) · Liver Transplantation · doi:10.1002/lt.21520 · Cited by 49
Differential diagnosis in patients with suspected bile acid synthesis defects
Haas, D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i10.1067 · Cited by 47
Regulation of Aldo–Keto Reductases in Human Diseases
Chen, W., & Zhang, Y. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00035 · Cited by 43
Ueki, I., Kimura, A., Chen, H., Yorifuji, T., Mori, J., Itoh, S., Maruyama, K., Ishige, T., Takei, H., Nittono, H., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05669.x · Cited by 41
On the future of “omics”: lipidomics
Griffiths, W. J., Ogundare, M., Williams, C. M., & Wang, Y. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9274-4 · Cited by 38
Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke
Williams, S. R., Hsu, F., Keene, K. L., Chen, W., Nelson, S. C., Southerland, A. M., Madden, E. B., Coull, B. M., Gogarten, S. M., Furie, K. L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002319 · Cited by 39
Shah, S., Conlin, L. K., Gomez, L. M., Aagenæs, Ø., Eiklid, K. L., Knisely, A. S., Mennuti, M. T., Matthews, R. P., Spinner, N. B., & Bull, L. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075770 · Cited by 36
Aldo-keto Reductase 1B15 (AKR1B15)
Weber, S., Salabei, J. K., Möller, G., Kremmer, E., Bhatnagar, A., Adamski, J., & Barski, O. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610121 · Cited by 35
Attempt to Determine the Prevalence of Two Inborn Errors of Primary Bile Acid Synthesis
Jahnel, J., Zöhrer, E., Fischler, B., D’Antiga, L., Debray, D., Dezsőfi, A., Haas, D., Hadžić, N., Jacquemin, E., Lamireau, T., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001546 · Cited by 39
Bile Acid Synthesis Disorders in Arabs
Al‐Hussaini, A. A., Setchell, K. D. R., Alsaleem, B., Heubi, J. E., Lone, K., Spraul, A., & Jacquemin, E. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001734 · Cited by 34
Faucher, F., Cantin, L., Luu-The, V., Labrie, F., & Breton, R. (2008) · Biochemistry · doi:10.1021/bi800572s · Cited by 30
Chaudhry, A. S., Thirumaran, R. K., Yasuda, K., Yang, X., Fan, Y., Strom, S. C., & Schuetz, E. G. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.051672 · Cited by 29
Sharma, V., & Hiller, M. (2018) · Genome Biology and Evolution · doi:10.1093/gbe/evy243 · Cited by 29
A Comprehensive Evaluation of Steroid Metabolism in Women with Intrahepatic Cholestasis of Pregnancy
Pařı́zek, A., Hill, M., Dušková, M., Vı́tek, L., Velíková, M., Kancheva, R. L., Šimják, P., Koucký, M., Kokrdová, Z., Adamcová, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159203 · Cited by 27
A bile acid-related prognostic signature in hepatocellular carcinoma
Zhang, W., Zhang, Y., Wan, Y., Liu, Q., & Zhu, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-26795-7 · Cited by 27
Faucher, F., Cantin, L., Luu-The, V., Labrie, F., & Breton, R. (2008) · Biochemistry · doi:10.1021/bi801276h · Cited by 27
Seki, Y., Mizuochi, T., Kimura, A., Takahashi, T., Ohtake, A., Hayashi, S., Morimura, T., Ohno, Y., Hoshina, T., Ihara, K., et al. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9526-6 · Cited by 26
Jin, Y., Chen, M., & Penning, T. M. (2014) · Biochemical Journal · doi:10.1042/bj20140220 · Cited by 26
Aldo-keto reductase (AKR) superfamily website and database: An update
Huacachino, A. A., Joo, J., Narayanan, N., Tehim, A., Himes, B. E., & Penning, T. M. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111111 · Cited by 27
Chen, J.-Y., Wu, J., Kimura, A., Nittono, H., Liou, B., Lee, C., Chen, H., Chiu, Y., Ni, Y., Peng, S. S., et al. (2019) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2019.06.009 · Cited by 24
Nikolaou, N., Hodson, L., & Tomlinson, J. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105808 · Cited by 26
Muñoz, S., Méndez, L., Dasilva, G., Torres, J. L., Ramos‐Romero, S., Romeu, M., Nogués, M. R., & Medina, I. (2018) · Marine Drugs · doi:10.3390/md16100353 · Cited by 24
Maekawa, M., Shimada, M., Ohno, K., Togawa, M., Nittono, H., Iida, T., Hofmann, A. F., Goto, J., Yamaguchi, H., & Mano, N. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214568871 · Cited by 23
Genetic Disorders of Steroid Metabolism Diagnosed by Mass Spectrometry
Shackleton, C. H. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-76698-8_26 · Cited by 23
Primary ∆4-3-oxosteroid 5β-reductase deficiency: Two cases in China
Zhao, J. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i47.7113 · Cited by 22
Detlefsen, A. J., Paulukinas, R. D., & Penning, T. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031873 · Cited by 23
Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes
Zhang, M., Setchell, K. D. R., Zhao, J., Gong, J., Lu, Y., & Wang, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i7.859 · Cited by 21
Direct organocatalytic stereoselective transfer hydrogenation of conjugated olefins of steroids
Ramachary, D. B., Sakthidevi, R., & Reddy, P. S. (2013) · RSC Advances · doi:10.1039/c3ra41519h · Cited by 23
A combination of mutations in AKR1D1 and SKIV2L in a family with severe infantile liver disease
Morgan, N. V., Hartley, J., Setchell, K. D. R., Simpson, M. A., Brown, R., Tee, L. J., Kirkham, S., Pasha, S. S., Trembath, R. C., Maher, E. R., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-74 · Cited by 21
Hepatic miR-378 modulates serum cholesterol levels by regulating hepatic bile acid synthesis
Sun, C., Liu, W., Lu, Z., Li, Y., Liu, S., Tang, Z., Yan, Y., Li, Z., Feng, H., Zhang, D., et al. (2021) · Theranostics · doi:10.7150/thno.53624 · Cited by 19
Wang, H. H., Wen, F., Dai, D., Wang, J., Zhao, J., Setchell, K. D. R., Shi, L.-N., Zhou, S., Liu, S., & Yang, Q. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i35.4086 · Cited by 18
Disorders of Bile Acid Synthesis and Metabolism: A Metabolic Basis for Liver Disease
Setchell, K. D. R., & O’Connell, N. C. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.033 · Cited by 17
The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function
Mindnich, R., Drury, J. E., & Penning, T. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.12.020 · Cited by 16
5β-Dihydrosteroids: Formation and Properties
Penning, T. M., & Covey, D. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168857 · Cited by 15
Chiang, J. Y. L. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_12 · Cited by 15
Finkelstein, D., Lamba, V., Assem, M., Rengelshausen, J., Yasuda, K., Strom, S. C., & Schuetz, E. G. (2006) · Xenobiotica · doi:10.1080/00498250600861769 · Cited by 15
Developmental and Inherited Liver Disease
Quaglia, A., Roberts, E. A., & Torbenson, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00003-0 · Cited by 14
Corso, G., Russo, A. D., & Gelzo, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5257 · Cited by 15
Use of dried urine spots for screening of inborn errors of bile acid synthesis
Naritaka, N., Suzuki, M., Takei, H., Chen, H., Oh, S., Kaewplang, P., Zhang, C., Murai, T., Kurosawa, T., Kimura, A., et al. (2019) · Pediatrics International · doi:10.1111/ped.13852 · Cited by 13
Biopsy Diagnosis of Inherited Liver Disease
Roy, A., & Finegold, M. J. (2010) · Surgical pathology clinics · doi:10.1016/j.path.2010.06.006 · Cited by 14
Inborn errors of bile acid metabolism in Japan
Mizuochi, T., Takei, H., Nittono, H., & Kimura, A. (2023) · Pediatrics International · doi:10.1111/ped.15490 · Cited by 12
Chen, M., Jin, Y., & Penning, T. M. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00816 · Cited by 12
The effectiveness of correcting abnormal metabolic profiles
Clayton, P. T. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12139 · Cited by 12
Self-citationA new susceptibility locus for hypospadias on chromosome 7q32.2-q36.1
Thai, H. T. T., Söderhäll, C., Lagerstedt‐Robinson, K., Omrani, M. D., Frisén, L., Lundin, J., Kockum, I. S., & Nordenskjöld, A. (2008) · Human Genetics · doi:10.1007/s00439-008-0533-5 · Cited by 11
∆4-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid
Gardin, A., Ruiz, M., Beime, J., Cananzi, M., Rathert, M., Rohmer, B., Grabhorn, E. F., Almes, M., Logarajah, V., Quintana, L. P., et al. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02984-z · Cited by 11
Disorders of Bile Acid Synthesis
Clayton, P. T. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_34 · Cited by 11
Self-citationDisorders of bile acid synthesis and metabolism
Setchell, K. D. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012102.034 · Cited by 10
Differential Feedback Regulation of Δ4-3-Oxosteroid 5β-Reductase Expression by Bile Acids
Valanejad, L., Nadolny, C., Shiffka, S. J., Chen, Y., You, S., & Deng, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170960 · Cited by 11
Andrews, N. C., Anupindi, S. A., & Badizadegan, K. (2005) · New England Journal of Medicine · doi:10.1056/nejmcpc059016 · Cited by 9
Mocan, T., Kang, D. W., Molloy, B. J., Jeon, H., Sparchez, Z. A., Beyoğlu, D., & Idle, J. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-87921-5 · Cited by 8
Pham, A. N., Thi, K. B., Thi, M.-H. N., Ngo, D.-N., Naritaka, N., Nittono, H., Hayashi, H., Dao, T. T., Nguyen, K. T., Nguyen, H., et al. (2022) · Medicine · doi:10.1097/md.0000000000029476 · Cited by 7
Healthy Patients With AKR1D1 Mutation Not Requiring Primary Bile Acid Therapy: A Case Series
Kimura, A., Mori, J., Pham, A. N., Thi, K. B., Takei, H., Murai, T., Hayashi, H., & Nittono, H. (2023) · JPGN Reports · doi:10.1097/pg9.0000000000000372 · Cited by 6
Yanagi, T., Mizuochi, T., Homma, K., Ueki, I., Seki, Y., Hasegawa, T., Takei, H., Nittono, H., Kurosawa, T., Matsuishi, T., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12596 · Cited by 6
Waters, P. J., Khashu, M., Lillquist, Y. P., Senger, C., Mattman, A., Demos, M. K., Setchell, K. D. R., Rupar, C. A., Scott, P., Blau, N., et al. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.07.032 · Cited by 6
Clayton, P. T., Hirachan, R., & Murphy, E. (2025) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70081 · Cited by 5
Self-citationDisorders of Bile Acid Synthesis
Clayton, P. T. (2016) · Springer eBooks · doi:10.1007/978-3-662-49771-5_33 · Cited by 5
Self-citationDevelopmental and Inherited Liver Disease
Quaglia, A., Roberts, E. A., & Torbenson, M. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00003-x · Cited by 5
Penning, T. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00408-5 · Cited by 5
Disorders of Bile Acid Synthesis
Clayton, P. T. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_34 · Cited by 5
Self-citationThe Aldo-Keto Reductase Superfamily
Penning, T. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64092-8 · Cited by 4
Glucocorticoid Metabolism and Activation
Othonos, N., & Tomlinson, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64302-7 · Cited by 3
Bile Acid Metabolism During Development
David, E. S., Monteiro, I. M., & Ferraris, R. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3479-7.10119-3 · Cited by 3
Disorders of Bile Acid Synthesis
Clayton, P. T. (2022) · Springer eBooks · doi:10.1007/978-3-662-63123-2_38 · Cited by 3
Self-citationSteroid 5β-reductase (AKR1D1): Purification and characterization
Penning, T. M. (2023) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.04.012 · Cited by 2
Bissegger, S., & Langlois, V. S. (2016) · Mechanisms of Development · doi:10.1016/j.mod.2016.06.005 · Cited by 2
Other Inherited Metabolic Disorders of the Liver
Leonis, M. A., & Balistreri, W. F. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00076-7 · Cited by 2
Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action
Sbardella, E., & Tomlinson, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_14 · Cited by 2
Disorders of Bile Acid Synthesis and Biliary Transport
Lemonde, H. A., Gissen, P., & Clayton, P. T. (2014) · Springer eBooks · doi:10.1007/978-3-642-40337-8_34 · Cited by 2
Self-citationCheng, Y., Li, G., Deng, M., & Song, Y. (2017) · PubMed Central · doi:10.7499/j.issn.1008-8830.2017.07.002 · Cited by 2
Ferdinandusse, S., & Vaz, F. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-58819-8_14 · Cited by 1
Kędzierski, J., van Diest, R. E., Allard, J. A., Odermatt, A., & Smieško, M. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.02.009 · Cited by 1
Metadata
- Authors
- Lemonde, H. A., Custard, E. J., Bouquet, J., Duran, M., Overmars, H., Scambler, P. J., & Clayton, P. T.
- Affiliations
- Great Ormond Street Hospital (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Clayton, P T
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-09-11
- Volume
- 52
- Issue
- 10
- Pages
- 1494-1499
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC1773813
- OpenAlex
- W2020121378
- Cited by
- 125
- References
- 41
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 6 · 2023: 7 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 7 · 2012: 5
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- UvA-DARE (University of Amsterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Engineering and Physical Sciences Research Council
- Topics
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- AKR1D1, cholestatic liver disease, neonatal liver failure, giant cell hepatitis, extramedullary hematopoiesis, chenodeoxycholic acid, cholic acid, liver transplantation
- MeSH terms
- Chenodeoxycholic Acid, DNA Mutational Analysis, Female, Hepatitis, Humans, Infant, Newborn, Liver, Male, Oxidoreductases, Polymerase Chain Reaction, Liver Failure, Gene Deletion, Cholic Acid, Mutation, Missense, Spectrometry, Mass, Electrospray Ionization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
